Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members
- PMID: 34454787
- DOI: 10.1016/j.vaccine.2021.08.041
Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members
Abstract
Objectives: To evaluate the rates of myopericarditis (primary objective) and rates of cardiovascular and neurological adverse events (secondary objectives) in temporal association with ACAM2000® smallpox vaccine.
Methods: Observational cohort study conducted through monthly surveillance from 2009 to 2017 of electronic medical records of military service members (SM) for pre-specified cardiac and neurological International Classification of Diseases (ICD) codes reported in the 30 days following smallpox vaccination. ICD codes potentially predictive of myopericarditis and codes for encephalitis, Guillain-Barré syndrome, and sudden death were classified into Group 1. All other cardiovascular and neurological ICD codes were classified into Group 2. Medical records containing Group 1 codes were individually reviewed to confirm coding accuracy and to seek additional data in support of myopericarditis adjudication, which was performed by an independent clinical panel. Chart reviews were not performed for Group 2 codes, which were reported in aggregate only.
Results: 897,227 SM who received ACAM2000 smallpox vaccine and 450,000 SM who received Dryvax smallpox vaccine were included in the surveillance population. The rate of adjudicated myopericarditis among ACAM2000 smallpox vaccine recipients was 20.06/100,000 and was significantly higher for males (21.8/100,000) than females (8.5/100,000) and for those < 40 years of age (21.1/100,000) than for those 40 years or older (6.3/100,000). Overall rates for any cardiovascular event (Group 1 plus Group 2) were 113.5/100,000 for ACAM2000 vaccine and 439.3/100,000 for Dryvax vaccine; rate ratio, 0.26 (95% CI, 0.24-0.28). The rates of subjects with one or more defined neurological events were 2.12/100,000 and 1.11/100,000 for ACAM2000 and Dryvax vaccines respectively; rate ratio, 1.91 (95% CI, 0.71-5.10).
Conclusions: Electronic records surveillance of the entire vaccinated SM population over a ten-year period found rates of myopericarditis, of defined neurological events, and of overall cardiac events that were consistent with those of prior passive surveillance studies involving Dryvax or ACAM2000 smallpox vaccines.
Clinical trials registration: ClinicalTrials.gov NCT00927719.
Keywords: Cardiovascular adverse event; Myocarditis; Myopericarditis; Neurological adverse event; Pericarditis; Smallpox vaccine.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel.Vaccine. 2020 Oct 27;38(46):7323-7330. doi: 10.1016/j.vaccine.2020.09.037. Epub 2020 Sep 20. Vaccine. 2020. PMID: 32967791
-
Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.Vaccine. 2014 Aug 20;32(37):4758-65. doi: 10.1016/j.vaccine.2014.06.034. Epub 2014 Jun 18. Vaccine. 2014. PMID: 24951868 Free PMC article.
-
Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel.JAMA. 2003 Jun 25;289(24):3283-9. doi: 10.1001/jama.289.24.3283. JAMA. 2003. PMID: 12824210
-
Myopericarditis Associated With Smallpox Vaccination Among US Army Personnel - Fort Hood, Texas, 2018.Disaster Med Public Health Prep. 2022 Jun;16(3):1022-1028. doi: 10.1017/dmp.2020.478. Epub 2021 Mar 15. Disaster Med Public Health Prep. 2022. PMID: 33719991 Review.
-
Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(®) compared with Dryvax(®).Hum Vaccin Immunother. 2013 Jul;9(7):1489-96. doi: 10.4161/hv.24319. Epub 2013 Apr 9. Hum Vaccin Immunother. 2013. PMID: 23571177 Free PMC article. Review.
Cited by
-
Knowledge of Human Monkeypox Infection among Final Year Medical, Pharmacy, and Nursing Students: A Multicenter, Cross-Sectional Analysis from Pakistan.Healthcare (Basel). 2023 Oct 20;11(20):2777. doi: 10.3390/healthcare11202777. Healthcare (Basel). 2023. PMID: 37893851 Free PMC article.
-
Monkeypox scenario in India: a review study.Med Rev (2021). 2023 May 26;3(3):270-276. doi: 10.1515/mr-2023-0004. eCollection 2023 Jun. Med Rev (2021). 2023. PMID: 37789959 Free PMC article. Review.
-
Cardiac Adverse Events Following COVID-19 Vaccination in Patients With Prior Vaccine-Associated Myocarditis.Fed Pract. 2023 Jan;40(1):6-10. doi: 10.12788/fp.0354. Epub 2023 Jan 17. Fed Pract. 2023. PMID: 37223238 Free PMC article.
-
Myocarditis and pericarditis recovery following smallpox vaccine 2002-2016: A comparative observational cohort study in the military health system.PLoS One. 2023 May 8;18(5):e0283988. doi: 10.1371/journal.pone.0283988. eCollection 2023. PLoS One. 2023. PMID: 37155666 Free PMC article.
-
As the World Struggles With the COVID-19 Pandemic, Another Emergency Threat Arrives on the Horizon, the Monkeypox: A Systematic Review.Cureus. 2023 Jan 10;15(1):e33596. doi: 10.7759/cureus.33596. eCollection 2023 Jan. Cureus. 2023. PMID: 36655160 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical